Picture of Biomed Lublin Wytwornia Surowic i Szczepionek SA logo

BML Biomed Lublin Wytwornia Surowic i Szczepionek SA Balance Sheet

0.000.00%
pl flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Biomed Lublin Wytwornia Surowic i Szczepionek SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
C2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:ARSARSInterim ReportARSARS
Standards:
PAS
PAS
PAS
PAS
PAS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments2.320.0580.661.8419.5
Net Total Accounts Receivable
Net Total Receivables6.727.035.2310.611.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets21.814.314.82240.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment72.256.952.750.562.9
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets12186.381.185.9117
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities2622.320.224.617.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities63.255.948.248.642.3
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity57.830.432.937.374.6
Total Liabilities & Shareholders' Equity12186.381.185.9117
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email